United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

AI Briefing

• – New data to be presented includes pulmonary hypertension treatment and lung donor expansion, xenotransplantation research, and updates on the ARTISAN and PHINDER trials.
• – United Therapeutics Corporation presents 11 data presentations across its commercial and development portfolio at the ISHLT 2026 event.
• – Meetings will focus on advancements in heart and lung transplantation, with a focus on improving patient outcomes and expanding access to life-saving treatments.